Skip to main content
  1. Home

Submission Tool and Repository Measure Database

As the Centers for Medicare & Medicaid Services (CMS) consensus-based entity (CBE), Battelle Memorial Institute (Battelle) discloses complete information (e.g., full measure specifications, coding logic, algorithms) regarding each measure to the public for the purpose of evaluating, analyzing, or displaying of each measure for endorsement consideration. If an interested party wishes to attain complete measure information for the use and/or implementation of a measure, the interested party should contact the measure steward. Contact information for the measure steward can be found under the “Point of Contact” section of the respective measure page within the Submission Tool and Repository (STAR). Battelle is not responsible for, nor is privy to the measure use agreements that may be established between a measure steward and an interested party.

To obtain a copy of the full measure submission forms for measures endorsed prior to Fall 2023 cycle, please contact PQMSupport@battelle.org.

No Filters Selected
          CBE ID Title Steward Endorsement Cycle Status Previous Endorsement Cycle
          0060 Hemoglobin A1c (HbA1c) Testing for Pediatric Patients National Committee for Quality Assurance Endorsement Removed Spring 2014
          0061 Comprehensive Diabetes Care: Blood Pressure Control (<140/90 mm Hg) National Committee for Quality Assurance Endorsed Fall 2019
          0062 Comprehensive Diabetes Care: Medical Attention for Nephropathy National Committee for Quality Assurance Endorsement Removed Spring 2018
          0063 Comprehensive Diabetes Care: LDL-C Screening National Committee for Quality Assurance Endorsement Removed Spring 2014
          0064 Comprehensive Diabetes Care: LDL-C Control &lt;100 mg/dL National Committee for Quality Assurance Endorsement Removed Spring 2014
          0065 Chronic Stable Coronary Artery Disease: Symptom and Activity Assessment Physician Consortium for Performance Improvement Endorsement Removed Full Year 2010
          0066 Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%) American Heart Association Endorsed Spring 2020
          0067 Coronary Artery Disease (CAD): Antiplatelet Therapy American Heart Association Endorsed Spring 2020
          0068 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet National Committee for Quality Assurance Endorsement Removed Full Year 2015
          0069 Appropriate Treatment for Children With Upper Respiratory Infection (URI) National Committee for Quality Assurance Endorsed Fall 2020
          Displaying 61 - 70 of 1251

          The Submission Tool and Repository (STAR) is a measure database of quality performance measures that have been submitted to the previous consensus-based entity for endorsement review. The STAR database will be updated regularly as new and maintenance measures are submitted to the Partnership for Quality Measurement for endorsement review. Battelle will be providing additional enhancements to the STAR database as measure information is submitted in order to better support the accessibility of timely and accurate measure information for all interested parties.